NEW YORK--(BUSINESS WIRE)--NEMARIS, Inc. today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next-generation SURGIMAP 2.0 platform, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results